Clinical Trial Information Request for Protocol 2025P000440 Title A Phase 2b Randomized, Single-Center, Double blind, Placebo Controlled, 2-Arm Study to Investigate Orally Administered Combination Therapies (5-alpha reductase inhibitor + Raloxifene) Compared with Monotherapy (5-alpha reductase inhibitor + Placebo) in Adult Patients with Benign Prostatic Hyperplasia (BPH) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone